05/21/2025
7:42 AM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form DEF 14A | |
05/21/2025
7:45 AM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form DEFA14A | |
05/21/2025
7:47 AM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form ARS | |
05/14/2025
1:59 PM | Alaunos Therapeutics, Inc. (Subject)
Alaunos Therapeutics, Inc. (Subject)
Alaunos Therapeutics (Subject)
PMGC CAPITAL LLC (Filed by)
| Form SCHEDULE 13D | |
05/09/2025
8:09 AM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form PRE 14A | |
04/30/2025
3:59 PM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 10-K/A | |
04/15/2025
7:26 PM | Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics (Issuer)
Vieser Jaime (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/14/2025
8:15 AM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2025
3:15 PM | Alaunos Therapeutics, Inc. (Subject)
Alaunos Therapeutics, Inc. (Subject)
Alaunos Therapeutics (Subject)
MSD Partners, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
12/31/2024
4:10 PM | Alaunos Therapeutics, Inc. (Subject)
Alaunos Therapeutics, Inc. (Subject)
Alaunos Therapeutics (Subject)
Vieser Jaime (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
8:30 AM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/10/2024
7:30 AM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2024
3:35 PM | Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics (Issuer)
Groenewald Ferdinand (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
5:58 PM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 8-K/A | |
07/16/2024
5:58 PM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 8-K/A | |
07/16/2024
8:00 AM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2024
8:02 AM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
4:01 PM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy TCRT Stock Free TCRT Stock Alerts